Sphaera Bio Sciences

Sphaera Pharma is a global drug discovery and development organization that leverages proprietary technology platforms to create a diverse pipeline of small molecule therapeutics. With a primary focus on oncology, metabolic diseases, and inflammation, the company employs a strategy that integrates computational chemistry with traditional drug development. Sphaera is known for its collaborative model, frequently partnering with global pharmaceutical companies and academic institutions to advance its candidates through clinical trials. Its lead programs include a novel Renin inhibitor for hypertension and an LSD1 inhibitor for various cancers. The company maintains operations across India, Singapore, and the United States to facilitate international research and commercialization efforts.